These findings imply that hesperidin could serve as an effective inhibitor of renal cancer due to its capacity to reduce oxidative stress and ability to interfere with the COX-2/PGE2 pathway [29] (Table 1). This evidence concerns the gene PTGS2 and renal carcinoma.